Terms: = Brain cancer AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA AND Treatment
6 results:
1. Advances in treatment of alveolar soft part sarcoma: an updated review.
Fujiwara T; Kunisada T; Nakata E; Nishida K; Yanai H; Nakamura T; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2023 Nov; 53(11):1009-1018. PubMed ID: 37626447
[TBL] [Abstract] [Full Text] [Related]
2. Neratinib is a TFEB and tfe3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells.
Bellese G; Tagliatti E; Gagliani MC; Santamaria S; Arnaldi P; Falletta P; Rusmini P; Matteoli M; Castagnola P; Cortese K
Biochem Pharmacol; 2023 Jul; 213():115633. PubMed ID: 37269887
[TBL] [Abstract] [Full Text] [Related]
3. Significance of immunohistochemistry and FISH of tfe3 in the diagnosis of alveolar soft part sarcoma: A case report.
Huang YY; Yang WR; Geng YH; Zhang Y
Medicine (Baltimore); 2022 Jul; 101(27):e29861. PubMed ID: 35801771
[TBL] [Abstract] [Full Text] [Related]
4. Laparoscopic treatment of renal cancer in children: a multicentric study and review of oncologic and surgical complications.
Varlet F; Petit T; Leclair MD; Lardy H; Geiss S; Becmeur F; Ravasse P; Rod J; de Lambert G; Braik K; Lardellier-Reynaud F; Lopez M
J Pediatr Urol; 2014 Jun; 10(3):500-5. PubMed ID: 24332932
[TBL] [Abstract] [Full Text] [Related]
5. Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?
Genin O; Rechavi G; Nagler A; Ben-Itzhak O; Nazemi KJ; Pines M
Neoplasia; 2008 Sep; 10(9):940-8. PubMed ID: 18714394
[TBL] [Abstract] [Full Text] [Related]
6. Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO.
Alabran JL; Cheuk A; Liby K; Sporn M; Khan J; Letterio J; Leskov KS
Cancer Biol Ther; 2008 May; 7(5):709-17. PubMed ID: 18277094
[TBL] [Abstract] [Full Text] [Related]
